Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Infection-Related Neoplasm — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Neoplasm by Cause
Infection-Related Neoplasm

Cancer Family

Infection-Related Neoplasm

CI-CAN-00000207Explore in graph →

Non-malignant133 active trials4 approved drugs1 evidence items

NCIt: C27224

Overview
Statistics
Survival
Genomics
Variants & evidence1
Drugs
Trials539
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

539 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

StatusAll Active (any)Completed 261 Recruiting 89 Terminated 53 Active Not Recruiting 51 Unknown 36 Withdrawn 24 Not Yet Recruiting 19 Enrolling By Invitation 3 Suspended 2 No Longer Available 1

PhaseAll Early Phase 1 8 N/A 61 Phase 1 187 Phase 2 227 Phase 3 21 Phase 4 11

No study matches these filters